Approvals/TGA/COMIRNATY JN.1 (bretovameran) COVID-19 VACCINE 30 micrograms/0.3 mL suspension for injection multidose vial

Approved

STANDARD

COMIRNATY JN.1 (bretovameran) COVID-19 VACCINE 30 micrograms/0.3 mL suspension for injection multidose vial

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 197827e5c53096c5
Product Name: COMIRNATY JN.1 (bretovameran) COVID-19 VACCINE 30 micrograms/0.3 mL suspension for injection multidose vial
Artg Id: 457677
Artg Name: COMIRNATY JN.1 (bretovameran) COVID-19 VACCINE 30 micrograms/0.3 mL suspension for injection multidose vial
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2024-10-11
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-CMI-02705-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-PI-02704-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

197827e5c53096c5

Type

Standard